274 related articles for article (PubMed ID: 31879316)
21. Comparison of Long-term Survival of Patients With Early-Stage Non-Small Cell Lung Cancer After Surgery vs Stereotactic Body Radiotherapy.
Chi A; Fang W; Sun Y; Wen S
JAMA Netw Open; 2019 Nov; 2(11):e1915724. PubMed ID: 31747032
[TBL] [Abstract][Full Text] [Related]
22. Long term survival with stereotactic ablative radiotherapy (SABR) versus thoracoscopic sublobar lung resection in elderly people: national population based study with propensity matched comparative analysis.
Paul S; Lee PC; Mao J; Isaacs AJ; Sedrakyan A
BMJ; 2016 Jul; 354():i3570. PubMed ID: 27400862
[TBL] [Abstract][Full Text] [Related]
23. SABR vs. Limited Resection for Non-small Cell Lung Cancer: Are We Closer to an Answer?
Chen H; Louie AV
Curr Treat Options Oncol; 2016 Jun; 17(6):27. PubMed ID: 27098533
[TBL] [Abstract][Full Text] [Related]
24. Minimally invasive lobectomy versus stereotactic ablative radiotherapy for stage I non-small cell lung cancer.
de Ruiter JC; van Diessen JNA; Smit EF; van der Noort V; Damhuis RAM; Hartemink KJ;
Eur J Cardiothorac Surg; 2022 Aug; 62(3):. PubMed ID: 35348664
[TBL] [Abstract][Full Text] [Related]
25. Lobectomy versus stereotactic body radiotherapy in healthy patients with stage I lung cancer.
Rosen JE; Salazar MC; Wang Z; Yu JB; Decker RH; Kim AW; Detterbeck FC; Boffa DJ
J Thorac Cardiovasc Surg; 2016 Jul; 152(1):44-54.e9. PubMed ID: 27131846
[TBL] [Abstract][Full Text] [Related]
26. Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trial.
Ball D; Mai GT; Vinod S; Babington S; Ruben J; Kron T; Chesson B; Herschtal A; Vanevski M; Rezo A; Elder C; Skala M; Wirth A; Wheeler G; Lim A; Shaw M; Schofield P; Irving L; Solomon B;
Lancet Oncol; 2019 Apr; 20(4):494-503. PubMed ID: 30770291
[TBL] [Abstract][Full Text] [Related]
27. Stereotactic radiotherapy (SABR) for the treatment of primary non-small cell lung cancer; systematic review and comparison with a surgical cohort.
Soldà F; Lodge M; Ashley S; Whitington A; Goldstraw P; Brada M
Radiother Oncol; 2013 Oct; 109(1):1-7. PubMed ID: 24128806
[TBL] [Abstract][Full Text] [Related]
28. Surgery or radiotherapy for stage I lung cancer? An intention-to-treat analysis.
Spencer KL; Kennedy MPT; Lummis KL; Ellames DAB; Snee M; Brunelli A; Franks K; Callister MEJ
Eur Respir J; 2019 Jun; 53(6):. PubMed ID: 30635294
[TBL] [Abstract][Full Text] [Related]
29. Patterns of Recurrence and Survival after Surgery or Stereotactic Radiotherapy for Early Stage NSCLC.
van den Berg LL; Klinkenberg TJ; Groen HJM; Widder J
J Thorac Oncol; 2015 May; 10(5):826-831. PubMed ID: 25629639
[TBL] [Abstract][Full Text] [Related]
30. Stereotactic Ablative Radiation Therapy is Highly Safe and Effective for Elderly Patients With Early-stage Non-Small Cell Lung Cancer.
Brooks ED; Sun B; Zhao L; Komaki R; Liao Z; Jeter M; Welsh JW; O'Reilly MS; Gomez DR; Hahn SM; Heymach JV; Rice DC; Chang JY
Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):900-907. PubMed ID: 28258887
[TBL] [Abstract][Full Text] [Related]
31. Lobectomy Versus Stereotactic Body Radiotherapy in Healthy Octogenarians With Stage I Lung Cancer.
Razi SS; Kodia K; Alnajar A; Block MI; Tarrazzi F; Nguyen D; Villamizar N
Ann Thorac Surg; 2021 May; 111(5):1659-1665. PubMed ID: 32891656
[TBL] [Abstract][Full Text] [Related]
32. Stereotactic Ablative Radiation Therapy Versus Surgery in Early Lung Cancer: A Meta-analysis of Propensity Score Studies.
Chen H; Laba JM; Boldt RG; Goodman CD; Palma DA; Senan S; Louie AV
Int J Radiat Oncol Biol Phys; 2018 May; 101(1):186-194. PubMed ID: 29619964
[TBL] [Abstract][Full Text] [Related]
33. Impact of Lung Parenchymal-Only Failure on Overall Survival in Early-Stage Lung Cancer Patients Treated With Stereotactic Ablative Radiotherapy.
Elbanna M; Shiue K; Edwards D; Cerra-Franco A; Agrawal N; Hinton J; Mereniuk T; Huang C; Ryan JL; Smith J; Aaron VD; Burney H; Zang Y; Holmes J; Langer M; Zellars R; Lautenschlaeger T
Clin Lung Cancer; 2021 May; 22(3):e342-e359. PubMed ID: 32736936
[TBL] [Abstract][Full Text] [Related]
34. Stereotactic Radiation Therapy in Early Non-Small Cell Lung Cancer and Interstitial Lung Disease: A Nonrandomized Clinical Trial.
Palma DA; Bahig H; Hope A; Harrow S; Debenham BJ; Louie AV; Vu TTTT; Filion E; Bezjak A; Campeau MP; Duimering A; Giuliani ME; Laba JM; Lang P; Lok BH; Qu XM; Raman S; Rodrigues GB; Goodman CD; Gaede S; Morisset J; Warner A; Dhaliwal I; Ryerson CJ
JAMA Oncol; 2024 May; 10(5):575-582. PubMed ID: 38451491
[TBL] [Abstract][Full Text] [Related]
35. 7-year follow-up after stereotactic ablative radiotherapy for patients with stage I non-small cell lung cancer: Results of a phase 2 clinical trial.
Sun B; Brooks ED; Komaki RU; Liao Z; Jeter MD; McAleer MF; Allen PK; Balter PA; Welsh JD; O'Reilly MS; Gomez D; Hahn SM; Roth JA; Mehran RJ; Heymach JV; Chang JY
Cancer; 2017 Aug; 123(16):3031-3039. PubMed ID: 28346656
[TBL] [Abstract][Full Text] [Related]
36. A national analysis of wedge resection versus stereotactic body radiation therapy for stage IA non-small cell lung cancer.
Yerokun BA; Yang CJ; Gulack BC; Li X; Mulvihill MS; Gu L; Wang X; Harpole DH; D'Amico TA; Berry MF; Hartwig MG
J Thorac Cardiovasc Surg; 2017 Aug; 154(2):675-686.e4. PubMed ID: 28461054
[TBL] [Abstract][Full Text] [Related]
37. Video-assisted thoracoscopic lobectomy is associated with greater recurrence-free survival than stereotactic body radiotherapy for clinical stage I lung cancer.
Cornwell LD; Echeverria AE; Samuelian J; Mayor J; Casal RF; Bakaeen FG; Omer S; Preventza O; Mai W; Chen G; Simpson KH; Moghanaki D; Zhu AW
J Thorac Cardiovasc Surg; 2018 Jan; 155(1):395-402. PubMed ID: 28888379
[TBL] [Abstract][Full Text] [Related]
38. Stereotactic Ablative Radiotherapy for stage I histologically proven non-small cell lung cancer: an Italian multicenter observational study.
Ricardi U; Frezza G; Filippi AR; Badellino S; Levis M; Navarria P; Salvi F; Marcenaro M; Trovò M; Guarneri A; Corvò R; Scorsetti M
Lung Cancer; 2014 Jun; 84(3):248-53. PubMed ID: 24681279
[TBL] [Abstract][Full Text] [Related]
39. Is radiofrequency ablation more effective than stereotactic ablative radiotherapy in patients with early stage medically inoperable non-small cell lung cancer?
Bilal H; Mahmood S; Rajashanker B; Shah R
Interact Cardiovasc Thorac Surg; 2012 Aug; 15(2):258-65. PubMed ID: 22581864
[TBL] [Abstract][Full Text] [Related]
40. Measuring the population impact of introducing stereotactic ablative radiotherapy for stage I non-small cell lung cancer in Canada.
Louie AV; Rodrigues GB; Palma DA; Senan S
Oncologist; 2014 Aug; 19(8):880-5. PubMed ID: 24951606
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
